Table 1.
All patients (n = 617) | |
---|---|
Age (years) | 69 (61–77) |
Female gender | 169 (27.4) |
Hypertension | 448 (72.6) |
Dyslipidemia | 322 (52.2) |
Diabetes mellitus | 168 (27.2) |
Insulin dependent | 61 (9.9) |
Current or past smoker | 216 (35.0) |
Peripheral arterial disease | 47 (7.6) |
Atrial fibrillation | 65 (10.5) |
Previous stroke | 55 (8.9) |
Previous myocardial infarction | 180 (29.2) |
Previous coronary artery bypass surgery | 41 (6.6) |
Family history of coronary artery disease | 95 (15.4) |
β-Blocker use | 417 (67.6) |
Indication | |
NSTEMI | 28 (4.5) |
Unstable angina | 137 (22.2) |
Stable angina | 192 (31.1) |
Atypical angina | 63 (10.2) |
Silent ischemia | 197 (31.9) |
Multi-vessel disease | 444 (72.0) |
Previous percutaneous coronary intervention in the target vessel | 126 (20.4) |
All vessels (n=712) | |
Left main | 6 (0.8) |
Left anterior descending artery | 424 (59.6) |
Ramus intermedius | 11 (1.5) |
Right coronary artery | 143 (20.1) |
Left circumflex artery | 124 (17.4) |
Coronary artery bypass | 4 (0.6) |
Non-focal stenoses | 290 (40.7) |
Target segment | |
Proximal | 308 (43.3) |
Mid | 300 (42.1) |
Distal | 104 (14.6) |
Data are given in n (%) or median (Q1–Q3).